Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis
2009 · Modern Pathology · 31 citations
https://doi.org/10.1038/modpathol.2009.6
İ
İrem Hicran Özbudak
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
850
Citations
13
h-index
20
i10-index
İrem Hicran Özbudak is an academic researcher from Akdeniz University. The author has contributed to research in topics: Tumors and Oncological Cases & Sarcoma Diagnosis and Treatment & Medical Imaging and Pathology Studies. The author has an h-index of 13, co-authored 76 publications.
ORCID: 0000-0001-6687-1587Papers by this author
worksCluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
2005 · PubMed · 13 citations
Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7773956
Identification of novel mutations of Insulin Receptor Substrate 1 (IRS1) in tumor samples of non-small cell lung cancer (NSCLC): Implications for aberrant insulin signaling in development of cancer
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7866035
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat